Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
PMCB · Form 4/A · Abecassis Michael M – PharmaCyte Biotech, Inc. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 73 · 7,256 total
HSCS: SCHEDULE 13D/A · ownership disclosure
HSCS · SCHEDULE 13D/A · 2026-10-24
BRR: SCHEDULE 13D/A · ownership disclosure
BRR · SCHEDULE 13D/A · 2026-10-23
INV: 8-K · delisting
INV · 8-K · 2026-10-23
ANDE: 8-K · leadership change
ANDE · 8-K · 2026-10-23
APXC: 6-K · prospectus supplement
APXC · 6-K · 2026-10-23
HKIT: 6-K · periodic report
HKIT · 6-K · 2026-10-23
IMRN: 6-K · offering registration
IMRN · 6-K · 2026-10-23
FFAI: S-3/A · shelf registration
FFAI · S-3/A · 2026-10-23
IMRN: 424B5 · prospectus supplement
IMRN · 424B5 · 2026-10-23
EDSA: 8-K · leadership change
EDSA · 8-K · 2026-10-23
XXII: 424B5 · prospectus supplement
XXII · 424B5 · 2026-10-23
EVTV: 8-K · debt financing
EVTV · 8-K · 2026-10-23
NTCL: 6-K · reverse split
NTCL · 6-K · 2026-10-23
AMSS: 8-K · amendment
AMSS · 8-K · 2026-10-23
PHGE: 8-K · offering registration
PHGE · 8-K · 2026-10-23
HTLM: 6-K · foreign private issuer
HTLM · 6-K · 2026-10-23
TDY: 10-Q · periodic report
TDY · 10-Q · 2026-10-23
TRAW: 8-K · material agreement
TRAW · 8-K · 2026-10-23
APXC: 6-K · offering registration
APXC · 6-K · 2026-10-23
ONFO: S-1 · offering registration
ONFO · S-1 · 2026-10-23
RMXI: 8-K · debt financing
RMXI · 8-K · 2026-10-23
TGL: 8-K · material agreement
TGL · 8-K · 2026-10-23
MDCX: 8-K · delisting
MDCX · 8-K · 2026-10-23
WULF: 8-K · debt financing
WULF · 8-K · 2026-10-23
UFG: 424B5 · prospectus supplement
UFG · 424B5 · 2026-10-23
IPW: S-3/A · shelf registration
IPW · S-3/A · 2026-10-23
BURU: 424B3 · prospectus supplement
BURU · 424B3 · 2026-10-23
C: 424B3 · prospectus supplement
C · 424B3 · 2026-10-23
CPAC: 6-K · acquisition merger
CPAC · 6-K · 2026-10-23
PINE: 8-K · offering registration
PINE · 8-K · 2026-10-23
XPON: 8-K · material agreement
XPON · 8-K · 2026-10-23
PREM: 8-K · leadership change
PREM · 8-K · 2026-10-23
FPH: 10-Q · periodic report
FPH · 10-Q · 2026-10-23
TAOX: S-3/A · shelf registration
TAOX · S-3/A · 2026-10-23
BTOG: 6-K · reverse split
BTOG · 6-K · 2026-10-23
STFS: 20-F · periodic report
STFS · 20-F · 2026-10-23
MCFT: 424B3 · prospectus supplement
MCFT · 424B3 · 2026-10-23
MCRP: 6-K · debt financing
MCRP · 6-K · 2026-10-23
GRDX: 8-K · leadership change
GRDX · 8-K · 2026-10-23
INSW: 8-K · material agreement
INSW · 8-K · 2026-10-23
ARTC: 8-K · leadership change
ARTC · 8-K · 2026-10-23
FUSE: 8-K · material agreement
FUSE · 8-K · 2026-10-23
AQB: 424B3 · prospectus supplement
AQB · 424B3 · 2026-10-23
DRI: 8-K · debt financing
DRI · 8-K · 2026-10-23
GGRP: S-3 · shelf registration
GGRP · S-3 · 2026-10-23
CPAC: 6-K · acquisition merger
CPAC · 6-K · 2026-10-23
ACAD: 8-K · leadership change
ACAD · 8-K · 2026-10-23
PMI: 8-K · material agreement
PMI · 8-K · 2026-10-23
FCAP: 8-K · earnings release
FCAP · 8-K · 2026-10-23
ALGT: 8-K · material agreement
ALGT · 8-K · 2026-10-23
ARDT: 8-K · leadership change
ARDT · 8-K · 2026-10-23
GTAO: S-1/A · offering registration
GTAO · S-1/A · 2026-10-23
CEPU: 6-K · share repurchase
CEPU · 6-K · 2026-10-23
AVBC: 8-K · earnings release
AVBC · 8-K · 2026-10-23
DLNG: 6-K · dividend
DLNG · 6-K · 2026-10-23
NU: 6-K · leadership change
NU · 6-K · 2026-10-23
WDAY: 8-K · debt financing
WDAY · 8-K · 2026-10-23
HTH: 10-Q · periodic report
HTH · 10-Q · 2026-10-23
PLCE: 8-K · leadership change
PLCE · 8-K · 2026-10-23
ENSC: S-3 · offering registration
ENSC · S-3 · 2026-10-23
DDC: 6-K · earnings release
DDC · 6-K · 2026-10-23
SAFX: 8-K · material agreement
SAFX · 8-K · 2026-10-23
NCT: 424B5 · prospectus supplement
NCT · 424B5 · 2026-10-23
DFLI: 8-K · delisting
DFLI · 8-K · 2026-10-23
MEI: 8-K · leadership change
MEI · 8-K · 2026-10-23
HKD: 6-K · earnings release
HKD · 6-K · 2026-10-23
BUUU: 6-K · stock split
BUUU · 6-K · 2026-10-23
RNW: 6-K · asset sale
RNW · 6-K · 2026-10-23
TBH: 8-K · material agreement
TBH · 8-K · 2026-10-23
MASK: 6-K · reverse split
MASK · 6-K · 2026-10-23
SITM: 8-K · leadership change
SITM · 8-K · 2026-10-23
BNED: 8-K · leadership change
BNED · 8-K · 2026-10-23
BMI: 10-Q · periodic report
BMI · 10-Q · 2026-10-23
PINE: 424B5 · prospectus supplement
PINE · 424B5 · 2026-10-23
STRZ: 8-K · leadership change
STRZ · 8-K · 2026-10-23
MASK: 6-K · offering registration
MASK · 6-K · 2026-10-23
CNTY: 8-K · delisting
CNTY · 8-K · 2026-10-23
PINE: 424B5 · prospectus supplement
PINE · 424B5 · 2026-10-23
ATER: 8-K · debt financing
ATER · 8-K · 2026-10-23
BCPC: 10-Q · periodic report
BCPC · 10-Q · 2026-10-23
KMI: 10-Q · periodic report
KMI · 10-Q · 2026-10-23
DGX: 10-Q · periodic report
DGX · 10-Q · 2026-10-23
PHXE-P: 424B3 · prospectus supplement
PHXE-P · 424B3 · 2026-10-23
PHXE-P: 424B3 · prospectus supplement
PHXE-P · 424B3 · 2026-10-23
LASE: 8-K · delisting
LASE · 8-K · 2026-10-23
GGRP: 8-K · leadership change
GGRP · 8-K · 2026-10-23
HHH: 8-K · leadership change
HHH · 8-K · 2026-10-23
NIXX: 8-K · leadership change
NIXX · 8-K · 2026-10-23
CIVB: 8-K · leadership change
CIVB · 8-K · 2026-10-23
SEAT: 8-K · leadership change
SEAT · 8-K · 2026-10-23
WBUY: 6-K · offering registration
WBUY · 6-K · 2026-10-23
UMAC: 8-K · acquisition merger
UMAC · 8-K · 2026-10-23
FRPT: 8-K · leadership change
FRPT · 8-K · 2026-10-23
KRC: 10-Q · periodic report
KRC · 10-Q · 2026-10-23
M: 8-K · leadership change
M · 8-K · 2026-10-23
TMCR: 424B3 · prospectus supplement
TMCR · 424B3 · 2026-10-23
MFI: 6-K · other
MFI · 6-K · 2026-10-23
LVS: 10-Q · periodic report
LVS · 10-Q · 2026-10-23
JCTC: 8-K · asset sale
JCTC · 8-K · 2026-10-23
IPST: 10-Q · periodic report
IPST · 10-Q · 2026-10-23
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
73
Next ›
